Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity

The novel coronavirus, SARS-coronavirus (CoV)-2 (SARS-CoV-2), has caused over 17 million infections in just a few months, with disease manifestations ranging from largely asymptomatic infection to critically severe disease. The remarkable spread and unpredictable disease outcomes continue to challen...

Descripción completa

Detalles Bibliográficos
Autores principales: Loos, Carolin, Atyeo, Caroline, Fischinger, Stephanie, Burke, John, Slein, Matthew D., Streeck, Hendrik, Lauffenburger, Douglas, Ryan, Edward T., Charles, Richelle C., Alter, Galit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471005/
https://www.ncbi.nlm.nih.gov/pubmed/32878931
http://dx.doi.org/10.1128/mSphere.00622-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471005/
https://www.ncbi.nlm.nih.gov/pubmed/32878931
http://dx.doi.org/10.1128/mSphere.00622-20

Ejemplares similares